Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15116320 | 0.81 | ALDH1A1 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL47526 | 0.80 | CYP4F2 (0.37) | CYP4F2CYP4A11 | |
| SCHEMBL19872846 | 0.79 | CYP4F2 (0.35) | CYP4F2CYP4A11 | |
| SCHEMBL2597411 | 0.78 | CYP4F2 (0.32) | CYP4F2CYP4A11 | |
| SCHEMBL14873553 | 0.77 | CYP4F2 (0.52) | CYP4F2CYP4A11 | |
| SCHEMBL786780 | 0.77 | DGAT1 (0.41) | — | |
| SCHEMBL12345780 | 0.77 | DGAT1 (0.31) | — | |
| SCHEMBL807413 | 0.77 | PRKCA (0.42) | CYP4F2CYP4A11 | |
| SCHEMBL18856225 | 0.74 | HCAR2 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL12449512 | 0.74 | PRSS1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO LABS LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | BET1, PGGT1B, RABGGTB | CYP4F2 3880/4885CYP4A11 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.